You are here

Anti-Sm status and clinical-biological correlates of disease in SLE

Anti-Sm antibodies are present in a proportion of patients with SLE. We have discovered novel mechanisms of disease linked to Sm autoimmunity and HLA, with advanced work on translating this to a novel therapy. Now, we have a need to more deeply explore the associations of anti-Sm positivity with clinical outcomes and biological markers. Using the huge database managed at Monash, linked to thousands of biomarker datapoint, we will deliver this information.
Essential criteria: 
Minimum entry requirements can be found here:
systemic lupus erythematosus, lupus, antibodies, clinical, biomarkers, outcomes
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research » Medicine - Monash Medical Centre
Available options 
Masters by research
Time commitment 
Top-up scholarship funding available 
Physical location 
Monash Health Translation Precinct (Monash Medical Centre)

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.